Following the UK’s triggering of Article 50 to leave the European Union, the HPRA, together with medicines agencies in Europe, is making preparations to ensure that they continue to deliver on their patient and animal health remit even if the UK fully exits the current systems on 29 March 2019.
The HPRA wishes to engage with stakeholders to explain how the organisation is responding to the possible implications of Brexit and hear from them the key issues and concerns they have.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
